|
| |||||||||||||||||||||||||||||||||||||||
In the Results section of the text, under "Patients" (page 2145), the last sentence, "The median survival after transplantation was 1037 days (Fig. 1)," should have read, "The median survival after transplantation was 1260 days (Fig. 1)." Figure 1 (page 2145) should be replaced by the new Figure 1, which is available in the revised version of the article. The second, third, and fourth sentences of the legend to the figure, which read, "The median survival of these patients was 2.84 years (1037 days). The upper confidence limit shown here roughly matches the post-transplantation Kaplan–Meier survival curve in the report by Aurora et al.6 The rate of survival at 5 years was 32.9% — somewhat less than the 46.9% reported by the Organ Procurement and Transplantation Network for all recipients of lung transplants for cystic fibrosis2" should have read, "The median survival of these patients was 3.45 years (1260 days). The confidence limits shown here match those reported by Aurora et al.6 The rate of survival at 5 years was 39.5% — insignificantly less than the 46.9% reported by the Organ Procurement and Transplantation Network for all recipients of lung transplants for cystic fibrosis.2"
The first complete sentence on page 2146, "Burkholderia cepacia infection did not modify the effect of transplantation, but it was associated with decreased survival for all affected patients," should have read, "Burkholderia cepacia infection did not modify the effect of transplantation, but it has previously been associated with decreased survival for affected patients4,5 and is associated with a trend toward decreased survival in this population."
The second and third sentences in "Model Interpretation" (page 2147), which read, "Calculation of transplantation hazard factors according to age, diabetes status, and S. aureus infection status at the time of placement on the waiting list for each of the 514 children in the study showed hazard factors in four categories: significant estimated benefit (5 patients), significant risk of harm (315 patients), insignificant benefit (76 patients), and insignificant risk of harm (118 patients) (Fig. 2A). The distribution of estimated effects was similar for the 248 patients who underwent transplantation: 1 patient for whom transplantation was estimated to be beneficial, 162 for whom it was estimated to be harmful, and 85 for whom benefit was indeterminate (Fig. 2B)," should have read, "Calculation of transplantation hazard factors according to age, diabetes status, and S. aureus infection status at the time of placement on the waiting list for each of the 514 children in the study showed hazard factors in four categories: significant estimated benefit (5 patients), significant risk of harm (283 patients), insignificant benefit (102 patients), and insignificant risk of harm (124 patients) (Fig. 2A). The distribution of estimated effects was similar for the 248 patients who underwent transplantation: 1 patient for whom transplantation was estimated to be beneficial, 145 for whom it was estimated to be harmful, and 102 for whom benefit was indeterminate (Fig. 2B)."
Table 2 (page 2147) should be amended as shown. Values that have been changed are shown in red.
|
|
| |||||||||||||||||||||||||||||||||||||||
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |